| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.3 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.3 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |